RECENT ADVANCES IN PHYTOPHARMACEUTICAL INTERVENTIONS FOR THE MANAGEMENT OF TYPE 2 DIABETES

Ravina Patidar*, Somvardhan Singh Jaitawat, Ruchi Dashora, Dr. R. S. Tomar and Aditya Pant

Chronic hyperglycemia, which can be the result of impaired insulin secretion, insulin resistance, or both, is a sign of a complex metabolic disorder known as diabetes mellitus (DM) Though effective, conventional therapies often have limitations, including possible side effects, expenses, and limited glycemic control for some patients. Phytopharmaceuticals, which are standardized plant-derived compounds developed into scientifically validated formulations, have recently become promising alternatives and supplements for diabetes treatment. This review covers recent progress (2022–2025) in phytopharmaceutical studies aimed at type 2 diabetes mellitus (T2DM). It emphasizes preclinical and clinical results, mechanisms of action, and future pathways.